These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38050327)

  • 1. Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution.
    Price L; Garrity L; Stiehl S
    Pharmacotherapy; 2024 Feb; 44(2):141-148. PubMed ID: 38050327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses.
    Reinert JP; Maktabi L; Branam D; Snyder M
    Expert Rev Neurother; 2022 Mar; 22(3):231-236. PubMed ID: 35240911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid administration of undiluted intravenous levetiracetam.
    Haller JT; Bonnin S; Radosevich J
    Epilepsia; 2021 Aug; 62(8):1865-1870. PubMed ID: 34164804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid administration of undiluted loading doses of levetiracetam.
    Martinez S; Bonnin SS; Radosevich J; Haller JT
    Epilepsia; 2024 Mar; 65(3):615-619. PubMed ID: 38116700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Safety and Tolerability of Rapid Administration of Undiluted Intravenous Levetiracetam in Pediatrics.
    Giannaccini C; Almendras C; Li I; DiNapoli M; Macnow T
    J Child Neurol; 2024 Jun; 39(7-8):241-245. PubMed ID: 38798130
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback.
    Shim A; Radparvar S; Davis N; Kaplan A; Kantaris K; Devlin A; Liang J; Ciummo F
    J Pharm Pract; 2024 Jun; 37(3):722-727. PubMed ID: 37231709
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and Tolerability of Intravenous Push Lacosamide and Levetiracetam.
    Ragoonanan D; Tran N; Levesque M
    J Pharm Pract; 2023 Oct; 36(5):1056-1060. PubMed ID: 35348010
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and Tolerability of Rapid Administration Undiluted Levetiracetam.
    Morgan O; Medenwald B
    Neurocrit Care; 2020 Feb; 32(1):131-134. PubMed ID: 30919301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
    Gámez-Leyva G; Aristín JL; Fernández E; Pascual J
    CNS Drugs; 2009 Nov; 23(11):983-7. PubMed ID: 19845418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit.
    Adams T; Greathouse K
    Neurocrit Care; 2021 Dec; 35(3):789-793. PubMed ID: 34081297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
    Khongkhatithum C; Thampratankul L; Wiwattanadittakul N; Visudtibhan A
    Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of rapid infusion levetiracetam: A systematic review.
    Jense A; Douville A; Weiss A
    Pharmacotherapy; 2022 Jun; 42(6):495-503. PubMed ID: 35502462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of intravenous undiluted levetiracetam in pediatrics: A retrospective cohort study.
    Singh R; Troelstrup D; Dahl N
    Epilepsia; 2024 Oct; ():. PubMed ID: 39425903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency and safety of high-dose undiluted intravenous push levetiracetam loading doses compared to intravenous infusion in seizing patients: A retrospective cohort study.
    Koons M; Koehl J; Johnson R; Rosenthal ES; Webb AJ
    Epilepsia; 2024 Oct; 65(10):2888-2896. PubMed ID: 39126370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
    Zhang Y; Zhang Q; Zhang J
    Pharmacotherapy; 2024 May; 44(5):409-410. PubMed ID: 38853609
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to comment on "Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution".
    Price L; Garrity L; Stiehl S
    Pharmacotherapy; 2024 May; 44(5):411-412. PubMed ID: 38853603
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
    Burakgazi E; Bashir S; Doss V; Pellock J
    Clin EEG Neurosci; 2014 Apr; 45(2):89-91. PubMed ID: 24357676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.